New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
Trending
- Mirzapur The Movie Review 2026: Explosive Bhaukaal Saga Delivers Nostalgic Thrills
- Romanchakam Movie Review 2026: A Delightful Youthful Romance That Wins Hearts
- Immortal Movie Review 2026: A Bold Bat-Fantasy Horror That Bites Into New Territory
- Yen Ennai Edho Seidhai Movie Review 2026: A Heartfelt Slice-of-Life Triumph Worth Watching
- Jeevan Ya Bheema Con Review 2026: A Wildly Entertaining Mistaken-Identity Caper That Delivers Big Laughs
- Mahaprabhu Jagannath Movie Review 2026: A Divine Animated Triumph Families Will Love
- Gandhari Movie Review 2026: Taapsee Pannu Delivers a Gripping, Unmissable Thriller
- Why Vitamin D Deficiency Is So Common in India (Even With All That Sunshine)